-
公开(公告)号:US20250042979A1
公开(公告)日:2025-02-06
申请号:US18432414
申请日:2024-02-05
Applicant: GENENTECH, INC.
Inventor: Jillian Smith , Janice Smith , Geoff Kerchner
IPC: C07K16/18 , A61K9/00 , A61K31/13 , A61K31/185 , A61K31/405 , A61K31/4418 , A61K31/455 , A61K31/4745 , A61K31/519 , A61K39/00 , A61K39/395 , A61K45/06 , A61P25/28 , C07K16/00
Abstract: Methods of treating Alzheimer's Disease (AD) in patients suffering from early AD, including amyloid positive patients, ApoE4 positive patients, and patients suffering from prodromal or mild AD are provided.
-
公开(公告)号:US20250127891A1
公开(公告)日:2025-04-24
申请号:US18729273
申请日:2023-01-18
Applicant: Chugai Seiyaku Kabushiki Kaisha , Hoffmann-La Roche Inc. , Genentech, Inc.
Inventor: Takatoshi Ozawa , Hiroaki Ida , Hajime Ito , Shunsuke Yoshida , Jillian Smith , Sian Lennon-Chrimes , Gaelle Klingelschmitt , Hans-Christian Von Buedingen , Hanna Silber Baumann , James Overell , Sharmila Rajan
IPC: A61K39/395 , A61K31/52 , A61K31/5377 , A61K31/675 , A61K39/00 , A61K45/06
Abstract: All currently available treatment options for autoimmune encephalitis such as anti-NMDAR encephalitis and anti-LGI1 encephalitis carry substantial potential safety risks. Further, no approved therapies exist for anti-NMDAR encephalitis and anti-LGI1 encephalitis. The invention provides a means for a treatment for autoimmune encephalitis (AIE) such as NMDAR encephalitis and anti-LGI1 encephalitis, comprising an IL-6 inhibitor such as anti-IL-6 receptor antibody or antigen binding fragment thereof.
-
公开(公告)号:US20240076358A1
公开(公告)日:2024-03-07
申请号:US18165142
申请日:2023-02-06
Applicant: GENENTECH, INC.
Inventor: Jillian Smith , Janice Smith , Geoff Kerchner
IPC: C07K16/18 , A61K9/00 , A61K31/13 , A61K31/185 , A61K31/405 , A61K31/4418 , A61K31/455 , A61K31/4745 , A61K31/519 , A61K39/395 , A61K45/06 , A61P25/28 , C07K16/00
CPC classification number: C07K16/18 , A61K9/0019 , A61K31/13 , A61K31/185 , A61K31/405 , A61K31/4418 , A61K31/455 , A61K31/4745 , A61K31/519 , A61K39/3955 , A61K45/06 , A61P25/28 , C07K16/00 , A61K2039/505
Abstract: Methods of treating Alzheimer's Disease (AD) in patients suffering from early AD, including amyloid positive patients, ApoE4 positive patients, and patients suffering from prodromal or mild AD are provided.
-
公开(公告)号:US20230123110A1
公开(公告)日:2023-04-20
申请号:US17829750
申请日:2022-06-01
Applicant: GENENTECH, INC.
Inventor: Jillian Smith , Janice Smith , Geoff Kerchner
IPC: C07K16/18 , A61K31/185 , A61P25/28 , A61K31/4745 , C07K16/00 , A61K31/13 , A61K31/4418 , A61K31/405 , A61K9/00 , A61K31/455 , A61K39/395 , A61K31/519 , A61K45/06
Abstract: Methods of treating Alzheimer's Disease (AD) in patients suffering from early AD, including amyloid positive patients, ApoE4 positive patients, and patients suffering from prodromal or mild AD are provided.
-
公开(公告)号:US20210363230A1
公开(公告)日:2021-11-25
申请号:US17139493
申请日:2020-12-31
Applicant: GENENTECH, INC.
Inventor: Jillian Smith , Janice Smith , Geoff Kerchner
IPC: C07K16/18 , C07K16/00 , A61P25/28 , A61K9/00 , A61K31/13 , A61K31/185 , A61K31/405 , A61K31/4418 , A61K31/455 , A61K31/4745 , A61K31/519 , A61K39/395 , A61K45/06
Abstract: Methods of treating Alzheimer's Disease (AD) in patients suffering from early AD, including amyloid positive patients, ApoE4 positive patients, and patients suffering from prodromal or mild AD are provided.
-
公开(公告)号:US20200377582A1
公开(公告)日:2020-12-03
申请号:US16723550
申请日:2019-12-20
Applicant: GENENTECH, INC.
Inventor: Jillian Smith , Janice Smith , Geoff Kerchner
IPC: C07K16/18 , C07K16/00 , A61P25/28 , A61K9/00 , A61K31/13 , A61K31/185 , A61K31/405 , A61K31/4418 , A61K31/455 , A61K31/4745 , A61K31/519 , A61K39/395 , A61K45/06
Abstract: Methods of treating Alzheimer's Disease (AD) in patients suffering from early AD, including amyloid positive patients, ApoE4 positive patients, and patients suffering from prodromal or mild AD are provided.
-
公开(公告)号:US20190016791A1
公开(公告)日:2019-01-17
申请号:US16070150
申请日:2017-01-20
Applicant: GENENTECH, INC.
Inventor: Jillian Smith , Janice Smith , Geoff Kerchner
IPC: C07K16/18 , A61P25/28 , A61K9/00 , A61K39/395 , A61K45/06 , A61K31/13 , A61K31/4745 , A61K31/405 , A61K31/519 , A61K31/455 , A61K31/185 , A61K31/4418
Abstract: Methods of treating Alzheimer's Disease (AD) in patients suffering from early AD, including amyloid positive patients, ApoE4 positive patients, and patients suffering from prodromal or mild AD are provided.
-
-
-
-
-
-